Stanislava V. Nagorneva

Stanislava V. Nagorneva

Auto-generated profile, based on publicly available information

Stanislava V. Nagorneva

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2018 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
SNStanislava V. Nagorneva
Stanislava V. Nagorneva
VPVictoria S. Prokhorova
Victoria S. Prokhorova
ESElizaveta V. Shelaeva
Elizaveta V. Shelaeva
AKAlexandra M. Khudovecova
Alexandra M. Khudovecova
НВНагорнева Станислава Владимировна
Нагорнева Станислава Владимировна
ХМХудовекова Александра Михайловна
Худовекова Александра Михайловна
This article presents the data on the prevalence of congenital fetal anomalies in our hospital population obtained for the past five years (2013–2017). We analyzed the changes in their structure and the timing of diagnoses for the anomalies. In addition, the comparison of our results with international data was performed and extremely rare anomalies were described.

7 February 2023 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
EKEkaterina Kopteeva
Ekaterina Kopteeva
ESElizaveta V. Shelayeva
Elizaveta V. Shelayeva
Elena AlekseenkovaElena Alekseenkova
Elena Alekseenkova
SNStanislava V. Nagorneva
Stanislava V. Nagorneva
RKRoman V. Kapustin
Roman V. Kapustin
IKIgor Yu. Kogan
Igor Yu. Kogan
BACKGROUND: The high risk of adverse maternal and perinatal complications in patients with fetal growth restriction and diabetes mellitus requires a detailed assessment of the major risk factors and outcomes. AIM: The aim of this study was to determine the main risk factors for fetal growth retardation in pregnant women with pregestational and gestational diabetes mellitus, and to assess obstetric and perinatal outcomes in these patients. MATERIALS AND METHODS: We conducted a retrospective single-center cohort study at the premises of the Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott, Saint Petersburg, Russia. The study included 103 patients with type 1 diabetes mellitus, type 2 diabetes mellitus, or gestational diabetes mellitus with fetal growth retardation who delivered a singleton neonate from January 2017 to December 2021. Based on the antenatal diagnosis, the patients were divided into the following comparison groups: group I early fetal growth retardation (n = 29), group II late fetal growth retardation (n = 27), group III small for gestational age (n = 47). Relative risk calculations were used to assess the contribution of risk factors and the risk of developing secondary outcomes. RESULTS: Pregestational diabetes mellitus was the major risk factor for early fetal growth retardation development (relative risk 1.91; 95% confidence interval 1.043.50); especially type 1 diabetes mellitus (relative risk 1.64; 95% confidence interval 1.022.74) and more than 10 years of pregestational diabetes mellitus duration (relative risk 2.62; 95% confidence interval 1.126.17). Chronic hypertension increases the risk of early fetal growth retardation (relative risk 2.11; 95% confidence interval 2.213.68), while gestational hypertension was a significant risk factor for late fetal growth retardation development (relative risk 1.81; 95% confidence interval 1.013.70). Preeclampsia is associated with both early and late forms of fetal growth retardation. Maternal characteristics, such as age over 35 years, obesity, and in vitro fertilization pregnancy, increased the risk of early fetal growth retardation development. In turn, the presence of fetal growth retardation in patients with diabetes mellitus is associated with increased risk of cesarean section, prolonged stay of the newborn in the neonatal intensive care unit (5 days), low Apgar scores (7 at the 5th minute), and neonatal hypoglycemia. Early fetal growth retardation is a significant risk factor for preterm birth (relative risk 6.23; 95% confidence interval 2.8713.42) and fetal distress (relative risk 5.51; 95% confidence interval 2.2813.33). CONCLUSIONS: Being associated with a highly increased risk of adverse obstetric and perinatal outcomes, early fetal growth retardation in diabetic pregnancy is related to pregestational diabetes mellitus, especially type 1 diabetes mellitus, with a long history, as well as with hypertension in pregnancy.

21 December 2020 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
KKKhudovekova A.M. Khudovekova
Khudovekova A.M. Khudovekova
MMMozgovaya E.V. Mozgovaya
Mozgovaya E.V. Mozgovaya
NNNagorneva S.V. Nagorneva
Nagorneva S.V. Nagorneva
PVProkhorova V.S. Prokhorova V
Prokhorova V.S. Prokhorova V
SSSelkov S.A. Selkov
Selkov S.A. Selkov
CCChepanov S.V. Chepanov
Chepanov S.V. Chepanov

23 November 2023 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
ERElena I. Rusina
Elena I. Rusina
MZMaria M. Zhevlakova
Maria M. Zhevlakova
ESElizaveta V. Shelayeva
Elizaveta V. Shelayeva
SNStanislava V. Nagorneva
Stanislava V. Nagorneva
MYMaria Yarmolinskaya
Maria Yarmolinskaya
ЯИЯрмолинская Мария Игоревна
Ярмолинская Мария Игоревна
BACKGROUND:Stress urinary incontinence in women is a widespread disease. It can occur in women of reproductive age, while progressing and disrupting the quality of life. Ultrasound elastography allows for evaluating the stiffness of the urethral supporting structures and can help in studying the pathophysiology of stress urinary incontinence and in diagnosing its mild forms for timely initiation of therapy and preventing the development of severe forms of the disease. AIM:The aim of this study was to improve the diagnosis of mild stress urinary incontinence in women using ultrasound compression elastography of the ureterovesical junction. MATERIALS AND METHODS:We examined 25 women with mild stress urinary incontinence (main group) and 15 patients without urinary incontinence (control group) of reproductive and perimenopausal age. The diagnosis of stress urinary incontinence was confirmed during a comprehensive urodynamic study. To assess the urethral mobility and determine the stiffness of the supporting structures, a 2D ultrasound examination was performed with compression elastography of the ureterovesical junction using Voluson E6 and E10 ultrasound systems equipped with a transvaginal probe (GE Healthcare, USA). Four areas of interest in the paraurethral region of the proximal and middle urethra were examined. The obtained elastograms were used to evaluate the color characteristics and strain ratio of the areas of interest in three dimensions, the average values being calculated. RESULTS:The strain ratios in all studied areas of the paraurethral region had no significant relationship with age and were lower in patients with stress urinary incontinence compared to control values (p 0.01). Urethral hypermobility (mobility: mean urethral α angle rotation of 40 degrees) was identified in 84% of women with stress urinary incontinence. According to the results of correlation analysis, the strain ratios in the three areas of interest had a significant negative relationship with changes in the urethral α angle rotation. The ROC analysis showed that the stiffness values of the paraurethral region of the proximal posterior wall of the urethra are the most significant parameters for the diagnosis of stress urinary incontinence. The threshold value of the strain ratio for diagnosing stress urinary incontinence was determined to be less than or equal to 0.85 (sensitivity 96.0%; specificity 86.7%;p 0.001). CONCLUSIONS:Ultrasound compression elastography of the ureterovesical junction is a new non-invasive technique that can improve the accuracy of diagnosing stress urinary incontinence in women. It is advisable to use the technique in women with mild stress urinary incontinence who are planned for conservative treatment to confirm the diagnosis and monitor therapy.

17 October 2018 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
AKAlexandra M. Khudovekova
Alexandra M. Khudovekova
SNStanislava V. Nagorneva
Stanislava V. Nagorneva
VPVictoria S. Prokhorova
Victoria S. Prokhorova
EMElena V. Mozgovaya
Elena V. Mozgovaya
ХМХудовекова Александра Михайловна
Худовекова Александра Михайловна
МВМозговая Елена Витальевна
Мозговая Елена Витальевна
This article presents the results of searching for specific ultrasound criteria for diagnosis of pyelonephritis in pregnancy. The data obtained confirm low specificity of echographic criteria and show the possibilities of Doppler using in the diagnosis of pyelonephritis.

29 March 2023 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
MYMaria Yarmolinskaya
Maria Yarmolinskaya
MSMaria A. Shalina
Maria A. Shalina
SNStanislava V. Nagorneva
Stanislava V. Nagorneva
ЯИЯрмолинская Мария Игоревна
Ярмолинская Мария Игоревна
This article presents a modern review of the main classifications of adenomyosis based on the clinical course, the prevalence of the pathological process, the results of ultrasound and magnetic resonance imaging, and histological verification. The analysis is based on domestic and foreign literature, federal clinical recommendations, and results of our own research. Despite the large number of different classifications of the disease, there are still shortcomings noted in this review. Based on the available rubricators, we emphasized the need to create a classification of adenomyosis with an assessment of the clinical picture, genetic and molecular profiles, the results of non-invasive assessment methods, and a correlation with the histological conclusion. A unified classification would solve many problems in scientific and practical activities for accurate and early diagnosis of adenomyosis, identification of risk groups for patients with an aggressive course of the pathological process, selection of reasonable recommendations, and timely appointment of pathogenetic therapy.